These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 590978)

  • 21. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incorporation of 14-C-Glycine during galactosamine hepatitis of young and old rats (author's transl)a*].
    Platt D; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jul; 6(7):319-27. PubMed ID: 14537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced D-galactosamine hepatotoxicity after propylthiouracil treatment in the rat.
    Mihas TA; Ceballos R; Hirschowitz BI; Gibson RG; Mihas AA
    J Med; 1982; 13(1-2):71-9. PubMed ID: 6956652
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation.
    Müller-Berghaus G; Reuter C; Bleyl U
    Am J Pathol; 1976 Feb; 82(2):393-406. PubMed ID: 1251892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Specific hepatotoxic effect of D-galactosamine].
    Andreicut S; Kerekes M
    Morphol Embryol (Bucur); 1977; 23(3):221-5. PubMed ID: 142915
    [No Abstract]   [Full Text] [Related]  

  • 28. [The importance of intestinal endotoxins for the rise of toxic liver lesions from galactosamine].
    Grün M; Liehr H; Rasenack U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():251-60. PubMed ID: 800910
    [No Abstract]   [Full Text] [Related]  

  • 29. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 30. Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat.
    Grün M; Liehr H; Rasenack U
    Acta Hepatogastroenterol (Stuttg); 1977 Apr; 24(2):64-81. PubMed ID: 857560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The antihepatotoxic effect of silymarin on liver damage in rats induced by carbon tetrachloride, d-galactosamine and allyl alcohol].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1971 Aug; 21(8):1194-201. PubMed ID: 5110018
    [No Abstract]   [Full Text] [Related]  

  • 32. Protective effects of Alpha-tocopherol on the hepatotoxicity of D-galactosamine.
    Mihas AA; Doos W; Gibson RG; Hirschowitz BI
    Ala J Med Sci; 1976 Oct; 13(4):384-7. PubMed ID: 984338
    [No Abstract]   [Full Text] [Related]  

  • 33. New hepato-protective agents. I. Maleopimaric acid-4alpha-carboxamides.
    Danswan GW; Ramm PJ; Taylor JB
    Arzneimittelforschung; 1976; 26(12):2188-9. PubMed ID: 1037271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lidocaine as an immunomodulator in a toxic liver lesion].
    Uteshev BS; Prokopenko LG; Konoplia EN
    Eksp Klin Farmakol; 1997; 60(2):45-8. PubMed ID: 9206569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
    Leinweber B; Mahrt R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the behavior of microsomal enzymes in the rat liver following galactosamine administration].
    Leber HW; Leinweber B; Platt D
    Verh Dtsch Ges Inn Med; 1971; 77():1179-82. PubMed ID: 4346176
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine.
    Perings E; Brunner G; Vido I; Söling HD; Creutzfeldt W
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):130-4. PubMed ID: 4148023
    [No Abstract]   [Full Text] [Related]  

  • 38. Protective role of prednisolone upon galactosamine-induced hepatitis in rats.
    Grases PJ; Reutter W; Lesch R
    G E N; 1972; 27(2):197-204. PubMed ID: 4201408
    [No Abstract]   [Full Text] [Related]  

  • 39. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advantages and limitations of the galactosamine model].
    Decker K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():245-9. PubMed ID: 1029184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.